Clinical Trials Directory

Trials / Unknown

UnknownNCT06125262

Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.

Trajectory Analysis of Neutrophil to Lymphocyte Ratio(NLR) and Its Association With Efficacy of Immunochemotherapy in Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Guangdong Provincial People's Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Conduct a retrospective and prospective study to confirm the association between blood cells counts and the efficacy and safety in immunochemotherapy in patients with advanced esophageal cancer.

Detailed description

Studies have already demonstrated the feasibility of prognostic role of protein biomarkers change during the treatment trajectory of patients in several carcinoma,However, no study focused on the value of trajectory analysis of blood cells counts of Immunochemotherapy in patients with advanced esophageal cancer. The investigators plan to analyze the dynamic change of blood cells counts longitudinally from preoperation to long term follow-up in advanced esophageal cancer and predict the efficacy and safety of immunochemotherapy.

Conditions

Timeline

Start date
2022-11-01
Primary completion
2024-06-30
Completion
2025-07-31
First posted
2023-11-09
Last updated
2023-12-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06125262. Inclusion in this directory is not an endorsement.

Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC. (NCT06125262) · Clinical Trials Directory